ANTI AGING HEALTH

 

Balding

Home

Medical Professionals

Medical Health Concerns

Case Studies

Contact Us
Wednesday, November 23rd 2005

Balding

Updated: 02/16/2005
Overview    
Hair shedding is part of a normal hair-growth cycle. At any given time, 90% of scalp hair is in a 2- to 6-year growth phase; 10% is in a 2- to 6-month dormant phase. When the dormant phase ends, hair is shed. New hair subsequently emerges from these follicles. Throughout a normal growth cycle, many hairs are shed. Loss of 50 to even 100 hairs daily is not cause for alarm. Noticeable thinning indicates significant hair loss or balding. Hair loss and balding are not life-threatening, but can cause emotional distress.

Hair loss results from aging, genetic pre-disposition, thyroid imbalance, eating disorders, illness, hormonal effects of birth control pills, pregnancy, or menopause, and certain medications. The most common cause of hair loss is a hereditary condition known as androgenetic alopecia (AGA). Balding runs in families.1

Hair loss caused by AGA in men and women is characterized by a gradual shrinking of hair follicles which shortens the life cycle of hair. As the growth cycle phase progressively shortens, newly grown hair is shorter and thinner until new hair growth eventually ceases entirely. Hair-thinning conditions can be treated. Consult a physician or dermatologist for an evaluation to determine the cause of thinning hair.2

 
Summary    
Several factors lead to hair loss in men and women, most notably androgenic alopecia, an inherited condition. Treatment is available. Early treatment produces better results. Balding is a cosmetic condition, usually resulting from genetic influences, aging, skin conditions, or certain medications. The most common forms of balding are male- and female-pattern baldness. Baldness has no cure. Oral prescription drugs such as Propecia® and Proscar® are available by prescription and over-the-counter preparations which contain minoxidil have benefits. Most hair-growth drugs prevent hair loss better than they re-grow hair. Taking aggressive steps today helps maintain healthy hair.
 
 
Nutritional Recommendations    
Hair loss has many causes, including aging, genetic pre-disposition, thyroid imbalance, eating disorders, illness, hormonal effects of birth control pills, pregnancy, menopause, and certain medications and medical treatments. There is no single “cure” for baldness. A product that is effective for one individual may provide only limited results for another. Combining traditional treatments with nutritional supplements and natural topical solutions improves chances of inhibiting pattern hair loss.

Conventional Therapy

  • At the first sign of thinning hair, consult a dermatologist to determine the cause.
  • Ask your physician if any prescription drug you take causes temporary hair loss.
  • Ask your physician about drugs that may revive hair growth.

Lifestyle Modification

  • Maintain a healthy diet that is low in fat and rich in whole foods.

Nutritional Supplements

Product Availability

Life Extension Mix, L-lysine, L-arginine, saw palmetto, green tea extract, grape seed extract, Dr. Proctor's Hair Shampoo and Advanced Hair Formula may be ordered by calling (800) 544-4440. European Prescription Hair Formula is available by prescription from a compounding pharmacy. Call (713) 960-1616 for details.

 
Table of Contents    
 

BALDING


OVERVIEW

Hair shedding is part of a normal hair-growth cycle. At any given time, 90% of scalp hair is in a 2- to 6-year growth phase; 10% is in a 2- to 6-month dormant phase. When the dormant phase ends, hair is shed. New hair subsequently emerges from these follicles. Throughout a normal growth cycle, many hairs are shed. Loss of 50 to even 100 hairs daily is not cause for alarm. Noticeable thinning indicates significant hair loss or balding. Hair loss and balding are not life-threatening, but can cause emotional distress.

Hair loss results from aging, genetic pre-disposition, thyroid imbalance, eating disorders, illness, hormonal effects of birth control pills, pregnancy, or menopause, and certain medications. The most common cause of hair loss is a hereditary condition known as androgenetic alopecia (AGA). Balding runs in families.1

Hair loss caused by AGA in men and women is characterized by a gradual shrinking of hair follicles which shortens the life cycle of hair. As the growth cycle phase progressively shortens, newly grown hair is shorter and thinner until new hair growth eventually ceases entirely. Hair-thinning conditions can be treated. Consult a physician or dermatologist for an evaluation to determine the cause of thinning hair.2


EPIDEMIOLOGY AND GENETICS

Genetic or hereditary hair loss does not discriminate between sexes or races. Approximately 40 million men or 2 out of 3 men in the United States have significant hair loss. About 25% have some form of balding by age 30, and 65% begin to bald by age 60. In women, the number affected by pattern-type hair loss is slightly less: about 30 million or 1 in 4. Thinning hair can occur anytime between ages 25 to 45, but most commonly hair loss presents after age 40. Hair loss occurs in about 25% of pre-menopausal women and in 38% of post-menopausal women.


Types of Hair Loss

Male-Pattern Baldness

Male-pattern balding, the most common type in men, usually starts at the temples and gradually recedes to form an "M" shape. Hair on the top of the head thins. Over time, hair takes on a horseshoe-shaped pattern. Some males have only a receding hairline or bald spots at the crown. Hair remaining in balding areas is long, thick, and pigmented and then changes into fine, non-pigmented hair that grows at a slow rate. Males losing hair during the mid-teen years are likely to become completely bald on top of their heads.3

Androgenetic alopecia (AGA) is a major factor in male-pattern baldness. AGA is attributed to androgens, hormones that are responsible for male characteristics. AGA has three causal factors: advanced age, an inherited tendency to early baldness, and overabundance of DHT (dihydrotestosterone, the most potent androgen in the hair follicle which is derived from testosterone). Testosterone is metabolized into DHT by 5-alpha-reductase, an enzyme produced in the prostate, adrenal glands, and scalp. DHT (and perhaps other androgens) causes hair follicles to shrink and enter a permanent dormant state. DHT triggers synthesis of transforming growth factor-beta2 (TGF-beta2) which suppresses epithelial cell proliferation and eventually leads to apoptotic cell death.4 TGF-beta2 is directly responsible for significant hair loss on a cellular level. Combating the effects of TGF-beta2, using combination therapy with current DHT and androgen inhibitors, may have a significant role in treating hair loss.5

Female-Pattern Baldness

Female-pattern baldness (or diffused thinning) is caused by aging, genetic susceptibility, and androgen.5 Female-pattern baldness usually begins about age 30. It becomes more noticeable by age 40 and can be quite evident following menopause. Female-pattern baldness usually causes hair to thin all over the head. It rarely progresses to near or total baldness. Female-pattern baldness causes permanent hair loss.

Telogen Effluvium

Telogen effluvium is an abnormal loss of hair caused by alteration of a normal hair cycle. In telogen effluvium, a large proportion of hair enters the dormant phase and hair shedding is greater than normal.6 Telogen effluvium can follow a case of flu or emotional stress7 or can occur after a pregnancy. Hormonal changes in pregnancy can cause increased numbers of hair follicles to remain in a growth phase. After pregnancy, an increased proportion of these hairs enter a dormant phase, a temporary self-correction that increases hair shedding.8 This condition is seen when birth control pills are stopped.9

Chemotherapeutic Hair Loss

Cancer chemotherapy cause hair cells to stop dividing, a usually transient condition.10 Hair can fall out for 3 to 4 months before growing back. When a drug is prescribed, ask your physician if a side effect is hair loss. Side effects of all prescription drugs are listed in the Physicians' Desk Reference. Pharmacists also have this information.

Alopecia Areata

Alopecia areata is a highly unpredictable, autoimmune skin condition that causes loss of scalp hair, facial hair, and hair elsewhere on the body It affects approximately 1.7% of individuals (over 4.7 million people) in the United States.11 In alopecia areata, affected hair follicles are mistakenly attacked by an individual’s immune system (white blood cells) and the hair growth stage is arrested. Alopecia areata typically begins with one or more small, round, smooth bald patches on the scalp. It can progress to total scalp hair loss (alopecia totalis) or total body hair loss (alopecia universalis).12 Alopecia areata affects males and females of all ages and races. Onset often begins in childhood when it can be emotionally devastating. Alopecia areata is not life-threatening, but is most certainly life-altering. Its sudden onset, recurrent episodes, and unpredictable course have profound psychological impact.

Trichotillomania

Trichotillomania is a psychological disorder (an impulse control disorder). Impulse control disorders are characterized by an uncontrollable urge (or impulse) to do something that harms one’s self or others. Trichotillomania patients repetitively pull their hair out at the root from the scalp, eyebrows, or eyelashes or chronically scratch or brush their hair. Trichotillomania affects 1 to 2% of the population, primarily children. Girls are more likely to be affected than boys.

Scarring Alopecia

Scarring alopecia describes skin scarred by burns, X-ray therapy, skin cancer, or severe injury which results in hair loss.


Other Causes of Hair Loss

Hair loss can occur from damage caused by hair styling processes and products and from twisting and pulling hair. Certain skin conditions cause hair loss and baldness. Hair loss can be caused by oral medications, including cholesterol-lowering drugs, Parkinson's medications,13 ulcer drugs,14 anticoagulants,15 anti-arthritics,16,17 drugs derived from vitamin A,18 epilepsy anticonvulsants,19 antidepressants,20 beta-blockers for hypertension, anti-thyroid agents,21 and anabolic steroids.


ANATOMY AND PHYSIOLOGY (STRUCTURE AND FUNCTION)

Each hair originates in a deep pouch-like structure in the epidermis (a hair follicle) which penetrates the dermis. A hair root extends down into the hair follicle and widens into an indented bulb at its base. Extending into the indentation is the papilla (the center of hair growth) which contains capillaries and nerves that supply a hair. Newly dividing cells at the base of the hair multiply, forcing cells above them upward. As cells move upward, they gradually die and harden into a hair shaft. A hair shaft has two layers: cuticle and cortex. The cuticle (outer layer) consists of flat, colorless, overlapping cells; the cortex is the inner layer. The cortex contains pigment and keratin, a tough protein. The cortex forms the bulk of a hair shaft. Coarse hair such as scalp hair contains an additional inner core (medulla). Hair is lubricated by sebaceous glands located in hair follicles. Illness or stress can lessen pigment secretion and cause hair shafts to whiten. Age-related whitening is genetically determined. Hair color is determined by pigment and air spaces in the cortex and medulla. Hair color and texture are inherited characteristics. Humans scalp hairs generally shed every 2 to 4 years; body hairs are shed more frequently.22


PATHOPHYSIOLOGY

In the scalp, a hair growth cycle has three main phases: anagen, catagen, and telogen. The anagen phase is the growth cycle typically lasts 3 to 5 years. On a healthy scalp, hair numbers approximately 100,000 and 90% of the follicles are continually in the anagen phase of hair growth. The catagen stage follows the end of the growth period when a follicle begins to become dormant. The telogen stage is a dormant or resting period that lasts 3 to 4 months. When the dormant phase ends, an old hair falls out. A hair follicle then returns to the anagen stage and a new hair begins to grow.23

An average rate of hair growth is about half an inch per month depending on hair follicles and age of an individual. On average, 50 to 60 scalp hairs are lost daily in a normal hair growth cycle and new hairs begin to grow from these follicles. Hair loss begins when less new hair begins the re-growth stage.


ETIOLOGY AND MECHANISMS OF ACTION

In male-pattern baldness, scalp hair in affected areas becomes shorter, finer, and less pigmented with successive growth cycles. This type of baldness, androgenic alopecia, is thought to be associated with the presence of dihydroxytestosterone (DHT), a metabolite of testosterone. Eunuchs have low levels of testosterone and do not lose scalp hair and men with genetic deficiency of 5-alpha-reductase (the enzyme that converts testosterone to DHT) do not have male-pattern baldness.24


PHARMACOLOGY


Traditional Approaches

A biopsy may be required to determine baldness type. A biopsy ascertains if hair follicles are normal.

Conventional choices can be used to treat hair loss: take better care of the scalp, use minoxidil (Rogaine®) and/or Proscar®, have hair transplants or a scalp reduction, or have hair replaced non-surgically.

Successful prevention and treatment of accelerated hair loss necessitates treating factors that are involved in contributing to the hair-loss process (excluding the genetic component).


Anti-Androgens

DHT (the male hormone dihydrotestosterone) is associated with premature hair loss. A wide variety of anti-androgens are used to prevent or reverse premature hair loss: progesterone, spironolactone (Aldactone®), flutamide (Eulexin®), finasteride (Proscar®), cimetidine (Tagamet®), Serenoa repens (Permixon® and cyproterone acetate (Androcur/Diane®). The most effective anti-androgens are oral finasteride (Propecia®, Proscar®).

In hair-loss, an immune reaction caused by male hormones (e.g., DHT) has perhaps the most significant role. Stimulated by androgens, the immune system targets hair follicles in genetically susceptible areas and causes premature hair loss characteristic of male-pattern baldness.25


Growth Stimulators

Topical oxygen free-radical scavengers (e.g., superoxide dismutases, SODs, enzymes that counter excessive free-radical activity) are potent hair-growth stimulators. SODs inhibits oxygen radicals and may inhibit a localized immune response implicated in hair loss and offset damage and inflammation.26 Unless immunologic factors involved in hair loss process are effectively treated, potential for significant hair re-growth may be very limited.

Available agents (e.g., Rogaine®) stimulate some degree of hair growth in some individuals, but cannot by themselves produce healthy hair and cosmetic benefits. A multi-modal approach is required that combines anti-androgens, autoimmune system protective agents, oxygen free-radical inhibitors, and other hair-growth stimulators to halt hair loss and generate hair re-growth.

Finasteride

Finasteride (Proscar®) was originally developed to treat benign prostatic hyperplasia (BPH). It is available by prescription in 5-mg tablets. Finasteride (Propecia®) is FDA-approved for hair loss treatment. It is available by prescription in 1-mg tablets for men at $45 to $50 per month. Propecia cannot be taken by women. Finasteride was once thought to be useless for androgenic alopecia treatment because it primarily affected 5-alpha-reductace, the type 2 DHT-producing enzyme. However, finasteride in doses as low as 0.2 mg daily maximally decrease scalp, skin, and serum DHT levels.27

Finasteride can produce visible hair growth in most men with mild-to-moderate alopecia and can stop hair loss in a majority of patients. Finasteride (1 mg daily over 5 years) was well-tolerated, produced durable improvement in scalp hair growth, and slowed further hair loss progression that occurred with no treatment.28 The most common side effect is decreased sexual desire or lowered amount of ejaculate (less than 2%, although men receiving placebo experienced the same side effects). Initial results of the Prostate Cancer Prevention Trial, produced concerns that finasteride might promote prostate cancer: finasteride was thought to reduce incidence of prostate cancer in men over 55 by one researcher; trial participants who developed prostate cancer had slightly more high-grade tumors.29

Dutasteride

Dutasteride (GG745), similar to Propecia®, blocks enzymatic conversion of testosterone to DHT. Unlike finasteride, dutasteride blocks two enzymes that create DHT rather than one and may be a more potent treatment for hair loss.30

Azulfidine

Azulfidine is an anti-inflammatory sulfa drug used to treat autoimmune disorders (e.g., rheumatoid arthritis and Crohn's disease). It is used in alopecia areata. Azulfidine completely reverses alopecia areata in 23% of participants. Although some re-growth occurred in other participants, the majority had no effect.31

Minoxidil

Originally used to treat high blood pressure, minoxidil is now widely used as a topical solution applied twice daily to treat male-pattern baldness. It may improve hair growth in 10 to 20% and slow hair loss in 90% of users. How minoxidil acts is unclear, but when effective, minoxidil appears to prolong the growing phase in the hair growth cycle, enlarge follicles, and cause dormant follicles to grow. Minoxidil may take 4 months or longer to produce results. Treatment is relatively expensive and must be continued indefinitely. When minoxidil is stopped, re-grown hair falls out. Newly grown hair may not be as long or thick as normal hair. Minoxidil is more effective in young men and men with recent-onset hair loss.32


Hair Transplantation

Early hair-grafting techniques were somewhat crude, often leaving a “patchwork” appearance. Newer techniques transplant productive hair follicles from a donor area on the scalp to a balding area. Hair follicles are commonly taken in plugs of one or two hairs (micrografts) from the sides or back of the head and moved to the front and/or top, slowly reconstructing a hairline. Larger plugs of up to 10 hairs can be used. Donor sites with full hair produce more successful transplants. The flap technique transplants larger areas of hair from the sides and back of the scalp to the top of the head. Some scarring at the donor site may result. Transplanted follicles can be permanent or last only a few years.


Scalp Reduction

Balding scalp areas can be surgically removed to decrease an appearance of baldness. Scalp reduction is usually used in conjunction with grafts or flaps. Prior to reduction, the scalp may be stretched to expand areas where hair is growing. Effectiveness of scalp reduction depends on degree of hair loss and scalp elasticity.


NUTRITIONAL THERAPY

A healthy diet, low in fat and high in fiber, fresh fruit, and vegetables, can have a major role in inhibiting hair loss associated with aging and genetics. In Asian countries, where vegetables are prevalent in standard dietary practices, pattern-type hair loss is rarely observed. Botanically-based nutrients may prevent hair follicles from entering a permanent dormant state. Nutritional supplements can provide some benefit.


Life Extension Mix

Life Extension Mix™ contains 92 unique vegetable, fruit and herbal extracts, amino acids, vitamins, minerals, and special antioxidants. Life Extension Mix™ formula is fortified with botanical extracts that help to maintain healthy cells via physiological processes separate from traditional antioxidants. Consumption of these types of plants is based on research from prestigious medical centers.


L-Lysine

A United States patent has been issued for L-lysine for treatment of various types of hair loss, including androgenetic alopecia. L-lysine (an amino acid) inhibits 5-alpha-reductase.33


L-Arginine

Hair follicles use nitric oxide to maintain and promote new hair growth. L-arginine is required to produce nitric oxide.34

Note: See Appendix C for Cautions and Contraindications


Saw Palmetto

Saw Palmetto (Serenoa repens) is a palm-like plant that is native to North America. An extract derived from saw palmetto berries contains fatty acids and sterols. Saw palmetto is commonly used to treat benign prostatic hyperplasia because it inhibits testosterone’s action on the prostate. Extracts of Saw Palmetto block 5-alpha-reductase, reduce DHT uptake by follicles, and block binding of DHT to androgen receptors. The liposterolic extract of saw palmetto combined with beta-sitosterol (a phytosterol common to many plants and grains) produced marked improvement.35


Green Tea Extract

Topical agents such as finasteride inhibit type II 5-alpha-reductase in hair follicles. Agents from tea (catechins, (-)epigallocatechin-3-gallate and (-)epicatechin-3-gallate) affect type I 5-alpha-reductase activity responsible for converting testosterone to DHT. All tea is derived from the same plant species, but types and varieties differ according to where and how the plants are grown and how the tea is produced. Catechins in green tea leaves are more potent. Black pekoe is allowed to dry and ferment, but green tea is not, thereby preserving catechin integrity.36

Note: See Appendix For Cautions and Contraindications


Proanthocyanidins and Procyanidins

Proanthocyanidins and procyanidins (specifically OPCs, oligomeric proanthocyanidins) are a class of flavonoids found in woody plants. Two common sources of OPCs are grape seeds (Vitis vinifera) and white pine (Pinus maritima, P. pinaster). Procyanidin B-2 and procyanidin B-3, which directly stimulate epithelial cell growth and check the growth-inhibiting effect caused by TGF-beta2, are of specific interest. Supplementing with 100 to 200 mg proanthocyanidins daily in the form of OPC Grape Seed Extract is suggested for adults.37


Complementary Topical Treatment

Dr. Proctor's Hair Formulas

Dr. Peter Proctor has developed a unique, multi-ingredient hair formula for balding that requires no prescription. Dr. Proctor's Hair Shampoo includes 3-carboxylic acid pyridine-N-oxide (NANO, known as "natural" minoxidil). This product can be used as a shampoo.

Dr. Proctor's Advanced Hair Formula includes NANO with natural hair protection and hair growth agents: endothelium-derived relaxing factor (EDRF) enhancers, SODs, and free-radical scavengers. Zinc sulfate and copper peptides are anti-androgens enhancing production of EDRF.38,39 This product is a liquid which can be applied to the scalp using eight to ten drops once or twice daily on thinning areas.


SUMMARY

Several factors lead to hair loss in men and women, most notably androgenic alopecia, an inherited condition. Treatment is available. Early treatment produces better results. Balding is a cosmetic condition, usually resulting from genetic influences, aging, skin conditions, or certain medications. The most common forms of balding are male- and female-pattern baldness. Baldness has no cure. Oral prescription drugs such as Propecia® and Proscar® are available by prescription and over-the-counter preparations which contain minoxidil have benefits. Most hair-growth drugs prevent hair loss better than they re-grow hair. Taking aggressive steps today helps maintain healthy hair.


LIFE EXTENSION’S INTEGRATED PROTOCOL

Hair loss has many causes, including aging, genetic pre-disposition, thyroid imbalance, eating disorders, illness, hormonal effects of birth control pills, pregnancy, menopause, and certain medications and medical treatments. There is no single “cure” for baldness. A product that is effective for one individual may provide only limited results for another. Combining traditional treatments with nutritional supplements and natural topical solutions improves chances of inhibiting pattern hair loss.


Conventional Therapy

  • At the first sign of thinning hair, consult a dermatologist to determine the cause.
  • Ask your physician if any prescription drug you take causes temporary hair loss.
  • Ask your physician about drugs that may revive hair growth.


Lifestyle Modification

  • Maintain a healthy diet that is low in fat and rich in whole foods.


Nutritional Supplements

  • L-lysine: 700 mg daily
  • L- arginine: 900 mg two times daily
  • Saw palmetto: 160 mg two times daily
  • Green tea extract: 725 mg daily
  • Grape seed extract: 100-200 mg daily
  • Life Extension Mix: Tablets, capsules or powder. Follow suggested dosage as listed on bottle

Product Availability

Life Extension Mix, L-lysine, L-arginine, saw palmetto, green tea extract, grape seed extract, Dr. Proctor's Hair Shampoo and Advanced Hair Formula may be ordered by calling (800) 544-4440. European Prescription Hair Formula is available by prescription from a compounding pharmacy. Call (713) 960-1616 for details.

For More Information

The National Alopecia Areata Foundation, P.O. Box 150760, San Rafael, CA 94915, (415) 456-4644.

The American Hair Loss Council, 401 North Michigan Avenue, Chicago, IL.

This Protocol was written by Karyn Siegel-Meier is a freelance writer and book author with an expertise in healing with herbs, alternative medicine, nutrition, general health, and new-age issues. Her work appears in many industry and consumer publications in the U.S., Canada, and the U.K.

Sections were written and edited by Randall Lee Kohl, Ph.D., R.Ph., F.C.P., Senior Editor for LE Publications, Inc. Address your comments only to: rkohl@lef.org. Direct your questions to the Life Extension Health Advisory staff at (800) 544-4440.


 
image   image

BALDING

REFERENCES

1. Birch MP, Messenger AG. Genetic factors predispose to balding and non-balding in men. Eur J Dermatol. 2001 Jul;11(4):309-14.

2. Stene JJ. [Alopecia areata and treatment]. Rev Med Brux. 2004 Sep;25(4):A282-A285.

3. Price VH. Androgenetic alopecia in adolescents. Cutis. 2003 Feb;71(2):115-21.

4. Hibino T, Nishiyama T. Role of TGF-beta2 in the human hair cycle. J Dermatol Sci. 2004 Jun;35(1):9-18.

5. Hibino T, Nishiyama T. Role of TGF-beta2 in the human hair cycle. J Dermatol Sci. 2004 Jun;35(1):9-18.

6. Whiting DA. Chronic telogen effluvium. Dermatol Clin. 1996 Oct;14(4):723-31.

7. Hadshiew IM, Foitzik K et al. Burden of hair loss: stress and the underestimated psychosocial impact of telogen effluvium and androgenetic alopecia. J Invest Dermatol. 2004 Sep;123(3):455-7.

8. Murray JC. Pregnancy and the skin. Dermatol Clin. 1990 Apr;8(2):327-34.

9. Gollnick H, Blume U et al. [Adverse drug reactions on hair]. Z Hautkr. 1990 Dec;65(12):1128-34.

10. Pierard-Franchimont C, Pierard GE. [How I explore...Hair loss in cancer patients]. Rev Med Liege. 2004 Sep;59(9):525-9.

11. Alexis AF, Dudda-Subramanya R et al. Alopecia areata: autoimmune basis of hair loss. Eur J Dermatol. 2004 Nov;14(6):364-70.

12. Alexis AF, Dudda-Subramanya R et al. Alopecia areata: autoimmune basis of hair loss. Eur J Dermatol. 2004 Nov;14(6):364-70.

13. Yamada K, Goto S. Bilateral subthalamic nucleus stimulation results in reversal of alopecia in Parkinson's disease. Parkinsonism Relat Disord. 2004 Aug;10(6):353-5.

14. Borum ML, Cannava M. Diffuse alopecia associated with omeprazole. Am J Gastroenterol. 1997 Sep;92(9):1576.

15. Sarris E, Tsele E et al. Diffuse alopecia in a hemodialysis patient caused by a low-molecular-weight heparin, tinzaparin. Am J Kidney Dis. 2003 May;41(5):E15.

16. Ettefagh L, Nedorost S et al. Alopecia areata in a patient using infliximab: new insights into the role of tumor necrosis factor on human hair follicles. Arch Dermatol. 2004 Aug;140(8):1012.

17. Gottenberg JE, Venancie PY et al. Alopecia areata in a patient with rheumatoid arthritis treated with leflunomide. J Rheumatol. 2002 Aug;29(8):1806-7.

18. Chave TA, Mortimer NJ et al. Agranulocytosis and total scalp alopecia following acitretin. Br J Dermatol. 2003 May;148(5):1063-4.

19. Kohno Y, Ishii A et al. [A case of hair loss induced by carbamazepine]. Rinsho Shinkeigaku. 2004 Jun;44(6):379-81.

20. Gautam M. Alopecia due to psychotropic medications. Ann Pharmacother. 1999 May;33(5):631-7.

21. Shelley ED, Shelley WB. Alopecia and drug eruption of the scalp associated with a new beta-blocker, nadolol. Cutis. 1985 Feb;35(2):148-9.

22. Hashimoto K. The structure of human hair. Clin Dermatol. 1988 Oct;6(4):7-21.

23. Paus R, Foitzik K. In search of the "hair cycle clock": a guided tour. Differentiation. 2004 Dec;72(9-10):489-511.

24. Kaufman KD. Androgens and alopecia. Mol Cell Endocrinol. 2002 Dec 30;198(1-2):89-95.

25. Alexis AF, Dudda-Subramanya R et al. Alopecia areata: autoimmune basis of hair loss. Eur J Dermatol. 2004 Nov;14(6):364-70.

26. Alexis AF, Dudda-Subramanya R et al. Alopecia areata: autoimmune basis of hair loss. Eur J Dermatol. 2004 Nov;14(6):364-70.

27. Drake L, Hordinsky M et al. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia. J Am Acad Dermatol. 1999 Oct;41(4):550-4.

28. FMPHLSG., The Finasteride Male Pattern Hair Loss Study Group. Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia. Eur J Dermatol. 2002;12(1):38-49.

29. Pitts WR, Jr. Finasteride (Propecia) and the promotion of high-grade prostate cancer. Arch Dermatol. 2004 Jul;140(7):885-6.

30. Bramson HN, Hermann D et al. Unique preclinical characteristics of GG745, a potent dual inhibitor of 5AR. J Pharmacol Exp Ther. 1997 Sep;282(3):1496-502.

31. Ellis CN, Brown MF et al. Sulfasalazine for alopecia areata. J Am Acad Dermatol. 2002 Apr;46(4):541-4.

32. Burke KE. Hair loss. What causes it and what can be done about it. Postgrad Med. 1989 May 1;85(6):52-73, 77.

33. Rushton DH. Nutritional factors and hair loss. Clin Exp Dermatol. 2002 Jul;27(5):396-404.

34. Shimizu Y, Sakai M et al. Immunohistochemical localization of nitric oxide synthase in normal human skin: expression of endothelial-type and inducible-type nitric oxide synthase in keratinocytes. J Dermatol. 1997 Feb;24(2):80-7.

35. Prager N, Bickett K et al. A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alpha-reductase in the treatment of androgenetic alopecia. J Altern Complement Med. 2002 Apr;8(2):143-52.

36. Liao S, Hiipakka RA. Selective inhibition of steroid 5 alpha-reductase isozymes by tea epicatechin-3-gallate and epigallocatechin-3-gallate. Biochem Biophys Res Commun. 1995 Sep 25;214(3):833-8.

37. Cos P, De Bruyne T et al. Proanthocyanidins in health care: current and new trends. Curr Med Chem. 2004 May;11(10):1345-59.

38. Neve HJ, Bhatti WA et al. Reversal of Hair Loss following Vertical Gastroplasty when Treated with Zinc Sulphate. Obes Surg. 1996 Feb;6(1):63-5.

39. Uno H, Kurata S. Chemical agents and peptides affect hair growth. J Invest Dermatol. 1993 Jul;101(1 Suppl):143S-7S.

 

 

image    
 

 





Copyright 2005-2009. ANTI-AGING-HEALTH.COM. All rights reserved.